239 related articles for article (PubMed ID: 83969)
21. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
22. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
23. High-frequency generation of new immunoresistant tumor variants during metastasis of a cloned murine tumor line (ESb).
Bosslet K; Schirrmacher V
Int J Cancer; 1982 Feb; 29(2):195-202. PubMed ID: 6977502
[TBL] [Abstract][Full Text] [Related]
24. Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells.
Schrader JW; Edelman GM
J Exp Med; 1976 Mar; 143(3):601-14. PubMed ID: 1082492
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
[TBL] [Abstract][Full Text] [Related]
26. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
27. Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes.
Bosslet K; Schirrmacher V
J Exp Med; 1981 Aug; 154(2):557-62. PubMed ID: 6167655
[TBL] [Abstract][Full Text] [Related]
28. F1 resistance to AKR lymphoma cells in vivo and in vitro.
Schmitt-Verhulst A-M ; Zatz MM
J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
[TBL] [Abstract][Full Text] [Related]
29. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
[TBL] [Abstract][Full Text] [Related]
30. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.
Schirrmacher V; Shantz G; Clauer K; Komitowski D; Zimmermann HP; Lohmann-Matthes ML
Int J Cancer; 1979 Feb; 23(2):233-44. PubMed ID: 761943
[No Abstract] [Full Text] [Related]
31. Expression of Ia antigens in a murine T-lymphoma variant.
Graf L; Koch N; Schirrmacher V
Mol Immunol; 1985 Dec; 22(12):1371-7. PubMed ID: 3938525
[TBL] [Abstract][Full Text] [Related]
32. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
33. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.
Colombo MP; Parenza M; Parmiani G
Cancer Immunol Immunother; 1985; 20(3):198-204. PubMed ID: 3851699
[TBL] [Abstract][Full Text] [Related]
34. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
Gorczynski RM; Knight RA
Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
[TBL] [Abstract][Full Text] [Related]
35. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
Igarashi T; Okada M; Kishimoto T; Yamamura Y
J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
[TBL] [Abstract][Full Text] [Related]
36. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
37. Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation.
Schild H; von Hoegen P; Schirrmacher V
Cancer Immunol Immunother; 1989; 28(1):22-8. PubMed ID: 2462467
[TBL] [Abstract][Full Text] [Related]
38. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
Mills GB; Paetkau V
J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
[TBL] [Abstract][Full Text] [Related]
39. T helper cells in immune mice amplify the primary anti-tumor cytotoxic response.
Yu AS; Bernstein ID
J Immunol; 1982 Aug; 129(2):856-9. PubMed ID: 6177788
[TBL] [Abstract][Full Text] [Related]
40. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
